Publicaciones de los grupos de investigación: marzo 2012
Pediatría
Carretero JM, Palacios JR, Prada F. Single coronary artery-right ventricular fistula. Cardiol Young 2012 ;22 (2) :209-12. Factor de impacto: 0,858.
Parra C, Asensio S, Trenchs V, Luaces C. Grupo de Trabajo de Catástrofes de la SEUP. ¿Estamos preparados para una catástrofe? Estudio multicéntrico español. An Pediatr (Barc) 2012 :in print. Factor de impacto: 0,570.
Enfermedades infecciosas e inmunopatología infantil
PLATO II, Observational HIV Epidemiological Research Europe Group. Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe. J Acquir Immune Defic Syndr 2012 ;59 (3) :294-9. Factor de impacto: 4,262.
PLATO II, Observational HIV Epidemiological Research Europe Group. Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.. Lancet Infect Dis 2012 ;12 (2) :119-27. Factor de impacto: 16,144.
Burgos AM, Villa AV, Noguera A, Fortuny C, González Enseñat MA. Fever and Skin Lesions in a Healthy 6-Month-Old Boy. Pediatr Infect Dis J 2012 :in print. Factor de impacto: 3,064.
Jordan I, Gargallo MB, Torné EE, Cambra FJ, VIñas AT, Tolosa CV, Rico AP. Procalcitonin: A useful biomarker to discriminate infection after cardiopulmonary bypass in children. Pediatr Crit Care Med 2012 :in print. Factor de impacto: 2,672.
Launes C, García García JJ, Martínez Planas A, Moraga F, Astigarraga I, Aristegui J, Korta J, Salado C, Quintana JM, Soldevila N, Domínguez A. CIBERESP. 2009 H1N1: risk factors for hospitalization in a matched case-control study. Eur J Pediatr 2012 :in print. Factor de impacto: 1,644.
Martín Mateos MA, Martorell A. SEICAP. Estado actual y expectativas de futuro de la inmunoterapia con alérgenos en el asma. An Pediatr (Barc) 2012 ;76 (4) :181-3. Factor de impacto: 0,570.
Morén C, Antón A, Garrabou G, Catalán M, Rovira N, Tobias E, Cardellach F, Miró O, Fortuny C. Mitochondrial evolution in HIV-infected children receiving first or second generation nucleoside analogues. J Acquir Immune Defic Syndr 2012 :in print. Factor de impacto: 4,262.
Noguera A, De José MI. Recomendaciones de la Sociedad Española de Infectología Pediátrica para el seguimiento del niño expuesto al virus de la immunodeficiencia humana y a fármacos antiretrovirales durante el embarazo y el período neonatal. An Pediatr (Barc) 2012 :in print. Factor de impacto: 0,570.
Enfermedades del adulto con origen fetal o en los primeros años de vida
García Aparicio L, Rodó J, Krauel L, Palazón P, Martín O, Ribó JM. High Pressure Balloon Dilation of the Ureterovesical Junction-First Line Approach to Treat Primary Obstructive Megaureter? J Urol 2012 :in print. Factor de impacto: 3,862.
Grynnerup A, Sánchez Fernández I, Calzada J, Deyà A, Muchart J, García Alix A. A Severe Valproate Overdose With Complete Recovery in a Newborn. J Child Neurol 2012 :in print. Factor de impacto: 1,668.
Prats Puig A, Grau Cabrera P, Riera Pérez E, Cortés R, Fortea E, Soriano P, De Zegher F, Ibáñez L, Bassols J, López Bermejo A. Variations in the obesity genes FTO, TMEM18 and NRXN3 influence the vulnerability of children to weight gain induced by short sleep duration. Int J Obes (Lond) 2012 :in print. Factor de impacto: 5,125.
Sebastiani G, Díaz M, López Bermejo A, Arranz A, De Zegher F, Ibáñez L. Circulating follistatin in the human foetus at term birth. Pediatr Obes 2012 ;7 (1) :39-43. Factor de impacto: 2,654.
Tenorio V, Alarcón A, García Alix A, Arca G, Camprubí M, Agut T, Figueras J. Hipotermia cerebral moderada en la encefalopatía hipóxico-isquémica: experiencia en el primer año de su puesta en marcha. An Pediatr (Barc) 2012 :in print. Factor de impacto: 0,570.
Van Mieghem T, Cruz Martínez R, Allegaert K, Dekoninck P, Castañón M, Sandaite I, Claus F, Devlieger R, Gratacós E, Deprest J. Outcome of fetuses with congenital diaphragmatic hernia and associated intrafetal fluid effusions managed in the era of fetal surgery. Ultrasound Obstet Gynecol 2012 ;39 (1) :50-5. Factor de impacto: 3,163.
Desarrollo neuronal y enfermedades metabólicas
Grillo E, Villard L, Clarke A, Ben Zeev B, Pineda M, Bahi-Buisson N, Hryniewiecka A, Bienvenu T, Armstrong J, Martínez AR, Mari F, Veneselli E, Russo S, Vignoli A, Pini G, Djuric M, Bisgaard AM, Mejaski V, Polgar N, Cogliati F, Ravn K, Pintaudi M, Melegh B, Craiu D, Djukic A, Renieri A. Rett Networked Database: An integrated clinical and genetic network of Rett syndrome databases. Hum Mutat 2012 :in print. Factor de impacto: 5,956.
Pérez Poyato M, Recansens MM, Abizanda IF, Jiménez RD, Lafuente AL, Sánchez VC, Rodríguez Revenga L, Coll MJ, Gort L, Poo P, Pineda M. Infantile neuronal ceroid lipofuscinosis: Follow-up on a Spanish series. Gene 2012 :in print. Factor de impacto: 2,266.
Biología molecular de los tumores en desarrollo
Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baró T, De Heredia CD, Torán N, Català A, Torrebadell M, Fortuny C, Cusí V, Carreras C, Díaz GA, Blander JM, Farber CM, Silvestri G, Cunningham C, Calvillo M, Dufour C, Notarangelo LD, Lougaris V, Plebani A, Casanova JL, Ganal SC, Diefenbach A, Aróstegui JI, Juan M, Yagüe J, Mahlaoui N, Donadieu J, Chen K, Cerutti A. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 2012 ;13 (2) :170-80. Factor de impacto: 25,668.
Salazar J, Altés A, Del Río E, Estella J, Rives S, Tasso M, Navajas A, Molina J, Villa M, Vivanco JL, Torrent M, Baiget M, Badell I. Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia. Pharmacogenomics 2012 :in print. Factor de impacto: 3,876.
Tecnologías sanitarias y resultados en Atención Primaria
Cuesta A, Luciano JV, Peñarrubia MT, García Campayo J, Fernández Vergel R, Arroyo M, Serrano Blanco A. FibroQol Study Group. Clinical dimensions of fibromyalgia symptoms and development of a combined index of severity: The CODI index. Qual Life Res 2012 :in print. Factor de impacto: 1,958.
Investigación e innovación en Cirugía
Jimeno J, Vallverdú H, Tubella J, Sánchez Pradell C, Comajuncosas J, Orbeal R, Hermoso J, Gris P, López Negre JL, Urgellés J, Parés D. Prospective analysis of clinician accuracy in the diagnosis of benign anorrectal pathology: the value of clinical information. Rev Esp Enferm Dig 2012 ;104 (3) :122-7. Factor de impacto: 1,130.
Parés D. The Importance of training in anorectal pathology among medical specialities. Colorectal Dis 2012 ;14 (4) :401-2. Factor de impacto: 2,728.
Etiopatogenia y tratamiento de los trastornos mentales graves
Drugowitsch J, Moreno Bote J, Churchland AK, Shadlen MN, Pouget A. The Cost of Accumulating Evidence in Perceptual Decision Making. J Neurosci 2012 ;32 (11) :3612-3628. Factor de impacto: 7,271.
McLaughlin KA, Gadermann AM, Hwang I, Sampson NA, Al-Hamzawi A, Andrade LH, Angermeyer MC, Benjet C, Bromet EJ, Bruffaerts R, Caldas JM, de Girolamo G, De Graaf R, Florescu S, Gureje O, Haro JM, Hinkov H, Horiguchi I, Hu C, Karam AN, Kovess V, Lee S, Murphy SD, Nizamie SH, Posada Villa J, Williams DR, Kessler RC. Parent psychopathology and offspring mental disorders: results from the WHO World Mental Health Surveys. Br J Psychiatry 2012 :in print. Factor de impacto: 5,947.
Ochoa S, Salvador Carulla L, Villalta V, Gibert K, Haro JM. DEFDEP Group. Use of functioning-disability and dependency for case-mix and subtyping of schizophrenia. Eur J Psychiatry 2012 ;26 (1) :5-20. Factor de impacto: 0,186.
Pousa E, Hurtado G, Noguer S, Domènech C, García M, López N, Negredo M, Penadés R, Reinares M, Serrano D, Dolz M, Gallo P. Effectiveness of family work interventions on schizophrenia: Evidence from a multicentre study in Catalonia. Int J Soc Psychiatry 2012 :in print. Factor de impacto: 1,106.
San L, Bernardo M, Gómez A, Martínez P, González B, Peña M. Socio-demographic, clinical and treatment characteristics of relapsing schizophrenic patients. Nord J Psychiatry 2012 :in print. Factor de impacto: 0,880.